Copyright
©The Author(s) 2017.
World J Nephrol. May 6, 2017; 6(3): 132-142
Published online May 6, 2017. doi: 10.5527/wjn.v6.i3.132
Published online May 6, 2017. doi: 10.5527/wjn.v6.i3.132
Figure 2 Nonadjusted cumulative incidence rate of end-stage renal disease among high adherence level compared with the low level of adherence of allopurinol over time in years.
ESRD: End-stage renal disease.
- Citation: Perreault S, Nuevo J, Baumgartner S, Morlock R. Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study. World J Nephrol 2017; 6(3): 132-142
- URL: https://www.wjgnet.com/2220-6124/full/v6/i3/132.htm
- DOI: https://dx.doi.org/10.5527/wjn.v6.i3.132